Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Pfizer Inc.

Pfizer Inc. (PFE) Stock Overview

Explore Pfizer Inc.’s financial performance, market position, analyst ratings, and future outlook.

PFE●NYSE
HealthcareDrug Manufacturers - General
$29.45
$0.09(0.31%)
U.S. Market opens in 3h 18m

Pfizer Inc. (PFE)

Meyka AI Score

Z

Key Financials

Market Cap167.8B
P/E Ratio41.66
EPS (TTM)$3.05
ROE0.05%
Fundamental Analysis

AI Price Forecasts

1 Month$29.85
3 Months$30.95
1 Year Target$29.86

PFE Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Pfizer Inc. (NYSE: PFE) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Pfizer Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of PFE on the NYSE shows an RSI of 50.08, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $29.86 for the NYSE listing.

Key metrics behind Pfizer Inc.'s NYSE-traded stock include a P/E ratio of 41.66 and a market capitalization of 167.8B. Combined with our AI analysis, these give both institutional and retail investors a clear view of PFE on the NYSE.

Price Performance (NYSE: PFE)

1-Day Change
0.27%
5-Day Change
1.27%
1-Month Change
4.10%
3-Month Change
10.59%
6-Month Change
14.06%
Year-to-Date (YTD) Change
18.23%
1-Year Change
15.41%
3-Year Change
1.59%
5-Year Change
-41.33%
All-Time (Max) Change
6754.003%

Contact Information

https://www.pfizer.com
212 733 2323
66 Hudson Boulevard East, New York City, NY, 10001-2192

Company Facts

750,000 Employees
IPO DateJun 1, 1972
CountryUS
Actively Trading

Frequently Asked Questions